
AEHR Test Systems ($AEHR) is scheduled to release its Q1 2025 earnings on July 8th, with analysts forecasting revenue of $15.12 million and an EPS of -$0.02. Recent insider trading shows a net sale by an executive, while institutional investor activity is bifurcated: 76 funds decreased their positions, including significant exits by Point72 Asset Management and Ameriprise Financial, yet 56 funds increased holdings, with notable additions from National Bank of Canada and Sculptor Capital.
Aehr Test Systems ($AEHR) is approaching its July 8th earnings release with a backdrop of cautious to negative investor sentiment. Analyst consensus forecasts revenue of $15.12 million and, notably, a negative earnings per share of -$0.02, setting a low bar for performance. This outlook is reinforced by recent trading activity from sophisticated market participants. Insider sentiment appears bearish, with the only open-market transaction in the past six months being a sale of approximately $45,335 worth of stock by an executive vice president, with no corresponding insider purchases. Institutional holdings data from the most recent quarter reveals a net outflow, as 76 funds decreased their positions compared to 56 that added shares. The selling pressure is significant, highlighted by Point72 Asset Management's complete liquidation of its $6.7 million stake and Ameriprise Financial's substantial 68% reduction of its position. While there is some contrarian buying, including a new position by Sculptor Capital and a large percentage increase by the National Bank of Canada, the weight of institutional divestment from prominent funds suggests a prevailing risk-off stance on AEHR leading into the earnings report.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.35
Ticker Sentiment